PaxMedica's Research on Low Dose Suramin for Autism : compar

TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to...

Related Keywords

David Hough , Scott Mcgowan , Michael Derby , Exchange Commission , Paxmedica Inc , Company Risk , Nasdaq , General Psychiatry , Chief Medical Officer , Autism Spectrum Disorder , Alice Mao , Reymundo Lozano , Constance Smith Hicks , Veronica Martinez Cerdeno , Zachary Rome , Miel Malan , Robert Findling , Autism Spectrum , Chronic Fatigue Syndrome , Annual Report , Nasdaq Pxmd , Paxmedica , Nc , Low Dose Suramin , Nnals Of General Psychiatry ,